• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Impact of tumor factors on the prognosis of patients with advanced cirrhosis (Child-Pugh class C) and hepatocellular carcinoma.

作者信息

Toyoda Hidenori, Kumada Takashi, Kiriyama Seiki, Sone Yasuhiro, Tanikawa Makoto, Hisanaga Yasuhiro, Hayashi Kazuhiko, Honda Takashi, Kuzuya Teiji, Nonogaki Koji, Shimizu Jun-Ichi

出版信息

J Gastroenterol Hepatol. 2005 Jun;20(6):963-5. doi: 10.1111/j.1440-1746.2005.03841.x.

DOI:10.1111/j.1440-1746.2005.03841.x
PMID:15946154
Abstract
摘要

相似文献

1
Impact of tumor factors on the prognosis of patients with advanced cirrhosis (Child-Pugh class C) and hepatocellular carcinoma.肿瘤因素对晚期肝硬化（Child-Pugh C级）和肝细胞癌患者预后的影响
J Gastroenterol Hepatol. 2005 Jun;20(6):963-5. doi: 10.1111/j.1440-1746.2005.03841.x.
2
Manganese superoxide dismutase activity and incidence of hepatocellular carcinoma in patients with Child-Pugh class A liver cirrhosis: a 7-year follow-up study.Child-Pugh A级肝硬化患者的锰超氧化物歧化酶活性与肝细胞癌发病率：一项7年随访研究
Liver Int. 2007 Aug;27(6):791-7. doi: 10.1111/j.1478-3231.2007.01485.x.
3
Incidence and predictors of hepatocellular carcinoma in patients with cirrhosis.肝硬化患者肝细胞癌的发病率及预测因素
Clin Gastroenterol Hepatol. 2007 Aug;5(8):938-45, 945.e1-4. doi: 10.1016/j.cgh.2007.02.039. Epub 2007 May 16.
4
May plasma cholesterol level be considered a neoplastic marker in liver disease from cirrhosis to hepatocellular carcinoma?血浆胆固醇水平能否被视为从肝硬化到肝细胞癌的肝脏疾病中的肿瘤标志物？
Ital J Gastroenterol Hepatol. 1999 Jan-Feb;31(1):61-5.
5
Incidence and risk factors of hepatocellular carcinoma in patients with primary biliary cirrhosis.原发性胆汁性肝硬化患者肝细胞癌的发病率及危险因素
Hepatology. 2010 Dec;52(6):2239; author reply 2239-40. doi: 10.1002/hep.24005.
6
[Screening for hepatocellular carcinoma in cirrhotic patients].[肝硬化患者肝细胞癌的筛查]
Gastroenterol Clin Biol. 2000 May;24(5 Pt 2):B92-4.
7
Impact of etiology of cirrhosis on the survival of patients diagnosed with hepatocellular carcinoma during surveillance.肝硬化病因对监测期间诊断为肝细胞癌患者生存的影响。
Am J Gastroenterol. 2007 May;102(5):1022-31. doi: 10.1111/j.1572-0241.2007.01100.x. Epub 2007 Feb 21.
8
[Cancer of the liver (analysis of autopsy data)].[肝癌（尸检数据分析）]
Klin Med (Mosk). 1989 Nov;67(11):47-9.
9
Hepatocellular carcinoma in sub-Saharan (tropical) Africa.撒哈拉以南（热带）非洲地区的肝细胞癌
Acta Med Hung. 1991;48(3-4):177-87.
10
Risk factors for hepatocellular carcinoma in HCV-cirrhosis: what we know and what is missing.丙型肝炎病毒相关性肝硬化患者肝细胞癌的危险因素：我们所了解的与缺失的内容。
J Hepatol. 2006 Jun;44(6):1013-6. doi: 10.1016/j.jhep.2006.04.001.

引用本文的文献

1
Management of Hepatocellular Carcinoma in Japan: JSH Consensus Statements and Recommendations 2021 Update.日本肝细胞癌的管理：2021年更新版日本肝脏学会共识声明与建议
Liver Cancer. 2021 Jun;10(3):181-223. doi: 10.1159/000514174. Epub 2021 May 19.
2
Elevated CA19-9 Is Associated With Increased Mortality In A Prospective Cohort Of Hepatocellular Carcinoma Patients.CA19-9 升高与肝癌患者前瞻性队列的死亡率增加相关。
Clin Transl Gastroenterol. 2015 Feb 5;6(2):e74. doi: 10.1038/ctg.2014.22.
3
Prognostic indicators in hepatocellular carcinoma: a systematic review of 72 studies.
肝细胞癌的预后指标：对72项研究的系统评价
Liver Int. 2009 Apr;29(4):502-10. doi: 10.1111/j.1478-3231.2008.01957.x. Epub 2008 Dec 24.
4
Prognostic factors and treatment effects for hepatocellular carcinoma in Child C cirrhosis.Child C 级肝硬化患者肝细胞癌的预后因素及治疗效果
Br J Cancer. 2008 Apr 8;98(7):1161-5. doi: 10.1038/sj.bjc.6604282. Epub 2008 Mar 18.